Atrial natriuretic peptide in the prevention of acute renal dysfunction after heart transplantation - a randomized placebo-controlled double-blind trial.
Maria TholénOscar KolsrudGöran DellgrenKristjan KarasonLukas LannemyrSven-Erik RickstenPublished in: Acta anaesthesiologica Scandinavica (2023)
The study failed to detect that ANP infusion attenuates renal dysfunction or decreases the incidence of AKI after heart transplantation.
Keyphrases
- placebo controlled
- double blind
- phase iii
- phase ii
- study protocol
- clinical trial
- oxidative stress
- liver failure
- acute kidney injury
- open label
- risk factors
- low dose
- squamous cell carcinoma
- phase ii study
- heart failure
- randomized controlled trial
- intensive care unit
- radiation therapy
- acute respiratory distress syndrome